Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone–resistant strains
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone–resistant strains
Authors
Keywords
Quinolone-resistant strains, <em class="EmphasisTypeItalic ">Stenotrophomonas maltophilia</em>, Bacteremia
Journal
BMC INFECTIOUS DISEASES
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-28
DOI
10.1186/s12879-019-4394-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic factors of health care–associated bloodstream infection in adult patients ≥40 years of age
- (2018) Hsuan-Yin Ma et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series
- (2017) Hirotaka Ebara et al. INTERNAL MEDICINE
- Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia
- (2016) Yong Duk Jeon et al. MEDICINE
- Risk factors for levofloxacin resistance in Stenotrophomonas maltophilia from respiratory tract in a regional hospital
- (2015) Chien-Jung Pien et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia
- (2015) María B. Sánchez Frontiers in Microbiology
- Clinical Factors Associated with Acquisition of Resistance to Levofloxacin inStenotrophomonas maltophilia
- (2014) Ji Hyeon Baek et al. YONSEI MEDICAL JOURNAL
- Monotherapy with Fluoroquinolone or Trimethoprim-Sulfamethoxazole for Treatment of Stenotrophomonas maltophilia Infections
- (2013) Yu Lin Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Can Levofloxacin Be a Useful Alternative to Trimethoprim-Sulfamethoxazole for Treating Stenotrophomonas maltophilia Bacteremia?
- (2013) Sun Young Cho et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from Korea, and the Activity of Antimicrobial Combinations against the Isolates
- (2013) Hae-Sun Chung et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Stenotrophomonas maltophilia bloodstream infection: Comparison between community-onset and hospital-acquired infections
- (2012) Ya-Ting Chang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan
- (2011) Hsiu Wu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996–2009
- (2010) H. Araoka et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Attributable mortality ofStenotrophomonas maltophiliainfections: a systematic review of the literature
- (2009) Matthew E Falagas et al. Future Microbiology
- Stenotrophomonas maltophilia: an emerging opportunist human pathogen
- (2009) W John Looney et al. LANCET INFECTIOUS DISEASES
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting
- (2008) Teresa C. Horan et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review
- (2008) J.I. Garcia Paez et al. JOURNAL OF HOSPITAL INFECTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started